Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OMB Likely Will Pledge 2005 User Fee Funds; Dec. 3 Is Round Two For MDMA

This article was originally published in The Gray Sheet

Executive Summary

A third-party audit of FDA review costs and workload data associated with the Medical Device User Fee & Modernization Act may be in the offing

You may also be interested in...



OMB’s FY 2005 Device Funding Request Leaves Industry Wary Of FDA Estimate

Legislative changes to the compensating adjustment factor affecting device user fee rates in fiscal 2005 and beyond could be accomplished if Congress revisits the MDUFMA "triggers" in 2004

OMB’s FY 2005 Device Funding Request Leaves Industry Wary Of FDA Estimate

Legislative changes to the compensating adjustment factor affecting device user fee rates in fiscal 2005 and beyond could be accomplished if Congress revisits the MDUFMA "triggers" in 2004

PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?

FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel